Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

Jaafar Bennouna, Javier Sastre, Dirk Arnold et al. · The Lancet Oncology · 2012

Cited by 1,164 works. doi:10.1016/s1470-2045(12)70477-1

Authors

References